NEW YORK, Feb. 13 (GenomeWeb News) - The National Cancer Institute last week said it plans to commit about $35.5 million over the next five years to fund projects designed to accelerate the implementation of proteomic analysis technology in monitoring cancer-relevant proteins and peptides in clinical samples.

 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Researchers suggest that genetic variations could influence the side effects people experience when using synthetic cannabinoids, the International Business Times reports.

An analysis has examined the makeup of researchers on Twitter and what they share, Nature News reports.

At Stat News, Jim Kozubek argues that the Broad Institute is pushing the boundary of what a nonprofit is.

In PNAS this week: gut microbes may affect honeybee weight, phenotype and gene expression changes in DiGeorge syndrome, and more.